No conviction changes recorded
Fair Value Distribution — percentile bands
100.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
-8.1%/yr
±2.5% · revenue growth to justify current price
FCF-Based Reverse DCF
-19.4%/yr
±0.8% · FCF growth to justify current price
THE GAP
Market pricing margin expansion or capex normalization
KEY VALUE DRIVERS
Spearman correlation — what moves this valuation most
Viterra integration adds 40% capacity in oilseed processing and diversifies into Canadian/Australian origins. Normalized EBITDA path to $3B+ is credible if synergies realized. Grain trading cycle is late-stage but Bunge's distribution network is irreplaceable.
Commodity price headwinds if grain cycles turn (La Nina ending). $14B debt is heavy — rising rates materially increase interest burden. Integration risk: Viterra culture clash, IT systems, regulatory requirements in multiple jurisdictions.
Viterra synergy realization below $300M by year 2, grain commodity price decline >20%, credit downgrade
Updated Mar 17
Bunge's Viterra integration is the key investment thesis. High leverage is manageable if synergies realized; cyclical commodity exposure is elevated given FY2025 strength.